Aytu Biopharma Inc
AYTU2.640USD
+0.240+10.00%
시장 운영 시간 （ET）시세는 15분 지연됩니다
16.29M시가총액
9.94P/E TTM
자세한 내용은 Aytu Biopharma Inc 회사
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
회사 정보
종목 코드 AYTU
회사 이름Aytu Biopharma Inc
상장일Oct 20, 2017
CEOMr. Joshua R. (Josh) Disbrow
직원 수99
유형Ordinary Share
회계 연도 종료Oct 20
주소7900 E. Union Avenue
도시DENVER
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호80237
전화17204376580
웹사이트https://aytubio.com/
종목 코드 AYTU
상장일Oct 20, 2017
CEOMr. Joshua R. (Josh) Disbrow
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
29.46K
+130.24%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
23.81K
+1.79%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
16.00K
--
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
11.15K
--
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
9.82K
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
29.46K
+130.24%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
23.81K
+1.79%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
16.00K
--
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
11.15K
--
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
9.82K
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
ADHD portfolio
15.39M
83.40%
Pediatric portfolio
3.06M
16.58%
Other
4.00K
0.02%
지역별USD
이름
수익
비율
United States
18.45M
100.00%
사업별
지역별
사업별USD
이름
수익
비율
ADHD portfolio
15.39M
83.40%
Pediatric portfolio
3.06M
16.58%
Other
4.00K
0.02%
주식 보유 통계
마지막 업데이트: Sat, Jun 28
마지막 업데이트: Sat, Jun 28
주주
주주 유형
주주
주주
비율
Nantahala Capital Management, LLC
12.11%
Kanen Wealth Management, LLC
6.39%
Lytton (Laurence W)
5.64%
Stonepine Capital Management, LLC
5.17%
Disbrow (Joshua R.)
1.71%
Other
68.99%
주주
주주
비율
Nantahala Capital Management, LLC
12.11%
Kanen Wealth Management, LLC
6.39%
Lytton (Laurence W)
5.64%
Stonepine Capital Management, LLC
5.17%
Disbrow (Joshua R.)
1.71%
Other
68.99%
주주 유형
주주
비율
Hedge Fund
14.00%
Investment Advisor/Hedge Fund
12.67%
Individual Investor
8.50%
Investment Advisor
0.65%
Other
64.18%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
67
3.22M
35.83%
+940.81K
2025Q1
66
2.05M
28.89%
-146.84K
2024Q4
71
2.05M
33.28%
-280.21K
2024Q3
75
2.20M
40.58%
-328.29K
2024Q2
78
2.26M
43.50%
-3.54K
2024Q1
82
1.99M
41.33%
-356.06K
2023Q4
85
1.96M
40.81%
-395.45K
2023Q3
91
1.92M
40.24%
-406.76K
2023Q2
100
1.89M
40.00%
+821.00K
2023Q1
134
705.12K
28.77%
-175.85K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Nantahala Capital Management, LLC
1.09M
12.11%
--
--
Jun 06, 2025
Kanen Wealth Management, LLC
573.36K
6.39%
+407.09K
+244.84%
Jun 26, 2025
Lytton (Laurence W)
506.61K
5.64%
+506.61K
--
Jun 09, 2025
Stonepine Capital Management, LLC
463.72K
5.17%
+56.17K
+13.78%
Mar 31, 2025
Disbrow (Joshua R.)
153.26K
1.71%
+66.67K
+76.99%
Jun 09, 2025
Renaissance Technologies LLC
76.82K
0.86%
+1.40K
+1.86%
Mar 31, 2025
Armistice Capital LLC
57.60K
0.64%
-92.40K
-61.60%
Mar 31, 2025
Geode Capital Management, L.L.C.
53.94K
0.6%
+11.21K
+26.23%
Mar 31, 2025
Citadel Advisors LLC
30.49K
0.34%
+19.43K
+175.66%
Mar 31, 2025
Disbrow (Jarrett T)
29.46K
0.33%
+16.67K
+130.24%
Jun 09, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
DFA Dimensional US Sustainability Core 1 ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
날짜
유형
비율
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Jan 05, 2023
Merger
20<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
Dec 08, 2020
Merger
10<1
